Guyana vs Singapore: Treatment success rate for patients treated for MDR-TB
Guyana
33.0%
in 2022
Singapore
39.0%
in 2022
Guyana rank
151st
Singapore rank
150th
Treatment success rate for patients treated for MDR-TB over time
- Guyana
- Singapore
How they compare
Singapore currently reports 39.0% against 33.0% in Guyana, a difference of 6.0%.
That makes Singapore's figure about 1.2 times Guyana's.
The two have swapped places 4 times across 11 shared years of data; in 2006 it was Singapore ahead.
Guyana ranks 151st and Singapore ranks 150th of 163 countries.
Across the 3 decades both report, Guyana averaged higher in 1 and Singapore in 2.
Head to head by decade
| Decade | Guyana | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 67.0% | 67.0% | Singapore |
| 2010s | 40.3% | 56.7% | 16.4% | Singapore |
| 2020s | 61.0% | 36.7% | 24.3% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Guyana or Singapore?
- Singapore, at 39.0% against 33.0% in Guyana as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Guyana and Singapore?
- 6.0%, with Singapore ahead.
- How many years of comparable data are there for Guyana and Singapore?
- 11 years are reported by both, from 2006 to 2022.
- How do Guyana and Singapore rank globally for treatment success rate for patients treated for mdr-tb?
- Guyana ranks 151st and Singapore ranks 150th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.